Results 111 to 120 of about 760 (151)

A Personalized Approach for Oligometastatic Prostate Cancer: Current Understanding and Future Directions. [PDF]

Cancers (Basel)
Alerasool P, Zhou S, Miller E, Anker J, Tsao B, Kyprianou N, Tsao CK.   +6 more
europepmc   +1 more source

Treatment of an Aggressive Gonadotroph Pituitary Neuroendocrine Tumor With ¹⁷⁷Lutetium DOTATATE Radionuclide Therapy. [PDF]

JCEM Case Rep
Gandhi C, Koumna S, Chik C.
europepmc   +1 more source

LES PPRT DANS LE DUNKERQUOIS : DES ARTIFICES D’UNE CONCERTATION OBLIGÉE À LA CONSTRUCTION DE COMPROMIS

, 2013
Grembo, Nicolas, Le Blanc, Antoine, Gibout, C., Zwarterook, Irénée, Calvo-Mendieta, Iratxe, Chambon, Mylène, Flanquart, Hervé, Frère, Séverine   +7 more
openaire   +1 more source

The neuroscience of cancer: Focus on neuropeptidergic systems. [PDF]

Acta Pharm Sin B
Dong Z, Wang Y, Jin W.
europepmc   +1 more source

Quantitative 177Lu-DOTATATE SPECT/CT is predictive of 6-month PRRT morphological response in midgut neuroendocrine tumors: a pilot study. [PDF]

EJNMMI Res
Megherbi I, Hoog C, Perrier M, Brixi H, Cadiot G, Hoeffel-Fornes C, Morland D.   +6 more
europepmc   +1 more source

PAC-1 Synergizes with Sunitinib to Enhance Cell Death in Pancreatic Neuroendocrine Tumors. [PDF]

ACS Pharmacol Transl Sci
Lee HY, Lee MR, Fan TM, Hergenrother PJ.
europepmc   +1 more source

PPRT : a hybrid point and polygon ray tracer for meshes

openaire   +1 more source